Melanotan 1 is a synthetic analogue of α-MSH, the melanocyte-stimulating hormone. It has been investigated for its ability to increase melanin production and enhance skin’s natural defense against UV exposure. Clinical studies of afamelanotide (a closely related analogue) demonstrated improvements in light tolerance and reduced symptoms in individuals with photosensitivity disorders. This has made Melanotan 1 a key focus in pigmentation and dermatology-related research.
 
Research Outcomes in Studies:
Increased skin pigmentation and melanin density.
Improved tolerance to UV exposure in clinical trials.
Reduced occurrence of sunburn in light-sensitive populations.
For laboratory research use only. Not for human or veterinary consumption. Not FDA evaluated.